Characterization of Prostate Cancer With 3T MR

Active, not recruitingOBSERVATIONAL

Enrollment

236

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

January 31, 2012

Study Completion Date

May 31, 2025

Conditions

Prostate Cancer

Trial Locations (1)

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Beth Israel Deaconess Medical Center

OTHER